1. Academic Validation
  2. Metabolic activation of TM5441 in vitro and in vivo: Formation of reactive metabolites and human enzymes involved

Metabolic activation of TM5441 in vitro and in vivo: Formation of reactive metabolites and human enzymes involved

  • Eur J Pharm Sci. 2020 Feb 15;143:105195. doi: 10.1016/j.ejps.2019.105195.
Su-Qin Lang 1 Wen-Hua Lang 2 Hai-Yan Yu 3 Li Wang 4
Affiliations

Affiliations

  • 1 Department of Outpatient, Weifang People's Hospital, Weifang 261041, Shandong Province, China.
  • 2 Department of Spine surgery, Affiliated Hospital of Weifang Medical University, Weifang 261031, Shandong Province, China.
  • 3 Department of Radiology, Weifang People's Hospital, Weifang 261041, Shandong Province, China.
  • 4 Department of Pharmacy, Jining No.1 People's Hospital, Jining 272011, Shandong Province, China. Electronic address: herb_medicine@sina.com.
Abstract

TM5441, a furan-containing drug, is an inhibitor of plasminogen activator inhibitor-1 (PAI-1), which can induce intrinsic Apoptosis of human Cancer cell lines. The aim of this study was to identify the reactive metabolites of TM5441 and to reveal the bioactivation pathways that are associated with its hepatotoxicity. The reactive metabolites were trapped by using glutathione (GSH) or N-acetyl-lysine (NAL) in rat, dog, and human liver microsomal incubation system after exposure to TM5441. Two metabolic activation pathways were disclosed. The first bioactivation pathway was dominated by Cytochrome P450 enzymes (CYP450s); TM5441 was metabolized into cis-2-butene-1,4-dial derivative dependent on NADPH, which can be trapped in the liver microsomal incubations fortified with GSH or NAL as trapping agents. Five metabolites (M1, M2, M9, M12 and M13) associated with GSH and three metabolites (M4, M7 and M14) associated with NAL were identified by liquid chromatography-high resolution mass spectrometry. The second bioactivation pathway was catalyzed by UDP-glucuronosyltransferases (UGTs); TM5441 was conjugated with glucuronide to form acyl-glucuronide (M10), which further reacted with GSH, resulting in the identification of a TM5441-S-acyl-GSH adduct (M11) in liver microsomal incubations fortified with uridine-5'-diphosphoglucuronidc acid (UDPGA) and GSH. M9, M10, M11, M12 and M13 were also detected in bile samples of rats given TM5441. Compared with rat, dog would display closer bioactivation profiles to human. The CYP450 Enzyme responsible for the bioactivation of TM5441 was mainly identified as CYP3A4, using human recombinant CYP450 Enzymes and specific inhibitory studies. The UGT Enzymes responsible for the bioactivation of TM5441 mainly involved UGT2B7, 1A1 and 1A4. These results facilitate the understanding of the bioactivation of TM5441 and potential toxicological implications.

Keywords

4-dial; Acylglucuronide; Cis-2-butene-1; Metabolic activation; Reactive metabolite; TM5441.

Figures
Products